Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Journal of Biopharmaceutical Statistics|April 26, 2011
Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development programSue-Jane Wang, H M James Hung, Robert O'NeillJournal of Biopharmaceutical Statistics|July 2, 2019
Commentary on "Applying CHW method to 2-in-1 design: gain or lose"Lu Cui, H M James Hung, Sue Jane WangBiometrical Journal. Biometrische Zeitschrift|January 7, 2006
A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trialsH M James Hung, Sue-Jane Wang, Robert O'NeillContemporary Clinical Trials|February 11, 2018
Evaluation of the extent of adaptation to sample size in clinical trials for cardiovascular and CNS diseasesSue-Jane Wang, Hua Peng, Hsien-Ming James HungStatistics in Medicine|August 29, 2012
Paradigms for adaptive statistical information designs: practical experiences and strategiesSue-Jane Wang, H M James Hung, Robert O'NeillEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 12, 2010
Adaptive design clinical trials and trial logistics models in CNS drug developmentSue-Jane Wang, H M James Hung, Robert O'NeillStatistics in Medicine|February 24, 2011
Flexible design clinical trial methodology in regulatory applicationsH M James Hung, Sue-Jane Wang, Robert O'NeillPharmaceutical Statistics|December 22, 2021
A targeted simulation-extrapolation method for evaluating biomarkers based on new technologies in precision medicineDong Wang, Sue-Jane Wang, Joshua Xu, et al.Journal of Biopharmaceutical Statistics|March 17, 2007
Issues with statistical risks for testing methods in noninferiority trial without a placebo ARMH M James Hung, Sue-Jane Wang, Robert O'NeillControlled Clinical Trials|February 20, 2002
Utility and pitfalls of some statistical methods in active controlled clinical trialsSue-Jane Wang, H M James Hung, Yi TsongPageof 8